KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Non-Current Assets: 2009-2024

Historic Other Non-Current Assets for Novavax (NVAX) over the last 16 years, with Dec 2024 value amounting to $24.0 million.

  • Novavax's Other Non-Current Assets rose 252.45% to $107.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.7 million, marking a year-over-year increase of 252.45%. This contributed to the annual value of $24.0 million for FY2024, which is 31.74% down from last year.
  • Per Novavax's latest filing, its Other Non-Current Assets stood at $24.0 million for FY2024, which was down 31.74% from $35.2 million recorded in FY2023.
  • Novavax's 5-year Other Non-Current Assets high stood at $35.2 million for FY2023, and its period low was $13.2 million during FY2020.
  • For the 3-year period, Novavax's Other Non-Current Assets averaged around $29.2 million, with its median value being $28.5 million (2022).
  • In the last 5 years, Novavax's Other Non-Current Assets surged by 85.65% in 2020 and then crashed by 31.74% in 2024.
  • Novavax's Other Non-Current Assets (Yearly) stood at $13.2 million in 2020, then skyrocketed by 83.77% to $24.3 million in 2021, then rose by 17.20% to $28.5 million in 2022, then increased by 23.50% to $35.2 million in 2023, then slumped by 31.74% to $24.0 million in 2024.